Recent Research Analysts’ Ratings Changes for Perspective Therapeutics (CATX)
A number of research firms have changed their ratings and price targets for Perspective Therapeutics (NYSE: CATX): 4/7/2025 – Perspective Therapeutics had its price target lowered by analysts at Truist Financial Co. from $21.00 to $10.00. They now have a “buy” rating on the stock. 3/31/2025 – Perspective Therapeutics had its “buy” rating reaffirmed by […]
10 Apr 19:00 · The Cerbat Gem